NumerixS Investment Technologies’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

NumerixS Investment Technologies’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-32,500	Closed	-$240K	–	1436
2016 Q2	$240K	Buy	+32,500	New	+$244K	0.03%	647
2016 Q1	–	Sell	-36,300	Closed	-$227K	–	1063
2015 Q4	$227K	Sell	36,300 -7,400	-17%	-$48.6K	0.03%	676
2015 Q3	$255K	Buy	43,700 +2,100	+5%	+$16.2K	0.03%	561
2015 Q2	$344K	Sell	41,600 -25,200	-38%	-$223K	0.05%	467
2015 Q1	$550K	Buy	66,800 +28,928	+76%	+$214K	0.1%	285
2014 Q4	$260K	Buy	+37,872	New	+$237K	0.09%	344

Other funds holding ARIA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

NumerixS Investment Technologies's ARIA Position: Q3 2016 in Review

NumerixS Investment Technologies sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 32,500 shares — an estimated $240K sold.

NumerixS Investment Technologies first reported a position in ARIA in Q4 2014 and held it in 6 quarters. The position peaked at $550K in Q1 2015. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

NumerixS Investment Technologies reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
NumerixS Investment Technologies sold 32,500 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $240K.
NumerixS Investment Technologies first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 6 quarters.
NumerixS Investment Technologies's Ariad Pharmaceuticals Inc position peaked at $550K in Q1 2015.
202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on NumerixS Investment Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.